uniQure N.V. (QURE) stock
QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.30−0.48 (-2.31%)
Close on Nov 18, 2026Market cap $1.41BP/E –Yield –
uniQure total assets
Total assets on the balance sheet at the end of each period.
uniQure's total assets was $985.10M at Jun 30, 2026. For fiscal 2025 it was $824.91M, up 48.2% from the year before. Over ten years it grew 12.1% a year on average. The highest annual figure on record is $831.69M in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $824.91M | +48.2% |
| FY2024 | Dec 31, 2024 | $556.54M | -33.1% |
| FY2023 | Dec 31, 2023 | $831.69M | +18.0% |
| FY2022 | Dec 31, 2022 | $704.96M | -12.9% |
| FY2021 | Dec 31, 2021 | $809.18M | +137.7% |
| FY2020 | Dec 31, 2020 | $340.40M | -24.1% |
| FY2019 | Dec 31, 2019 | $448.63M | +63.8% |
| FY2018 | Dec 31, 2018 | $273.91M | +30.7% |
| FY2017 | Dec 31, 2017 | $209.64M | +10.2% |
| FY2016 | Dec 31, 2016 | $190.27M | -27.6% |
| FY2015 | Dec 31, 2015 | $262.66M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $985.10M | +68.4% |
| Q1 FY2026 | Mar 31, 2026 | $778.71M | +28.6% |
| Q4 FY2025 | Dec 31, 2025 | $824.91M | +48.2% |
| Q3 FY2025 | Sep 30, 2025 | $888.38M | +37.6% |
| Q2 FY2025 | Jun 30, 2025 | $584.89M | -20.0% |
| Q1 FY2025 | Mar 31, 2025 | $605.40M | -21.4% |
| Q4 FY2024 | Dec 31, 2024 | $556.54M | -33.1% |
| Q3 FY2024 | Sep 30, 2024 | $645.81M | -25.9% |
| Q2 FY2024 | Jun 30, 2024 | $730.85M | -22.5% |
| Q1 FY2024 | Mar 31, 2024 | $770.05M | +22.0% |
| Q4 FY2023 | Dec 31, 2023 | $831.69M | +18.0% |
| Q3 FY2023 | Sep 30, 2023 | $871.55M | +36.6% |
| Q2 FY2023 | Jun 30, 2023 | $942.77M | +34.4% |
| Q1 FY2023 | Mar 31, 2023 | $631.00M | -16.7% |
| Q4 FY2022 | Dec 31, 2022 | $704.96M | -12.9% |
| Q3 FY2022 | Sep 30, 2022 | $638.23M | -17.6% |
| Q2 FY2022 | Jun 30, 2022 | $701.21M | -10.6% |
| Q1 FY2022 | Mar 31, 2022 | $757.15M | +108.1% |
| Q4 FY2021 | Dec 31, 2021 | $809.18M | +137.7% |
| Q3 FY2021 | Sep 30, 2021 | $774.63M | +121.0% |
| Q2 FY2021 | Jun 30, 2021 | $784.26M | +103.5% |
| Q1 FY2021 | Mar 31, 2021 | $363.85M | -12.2% |
| Q4 FY2020 | Dec 31, 2020 | $340.40M | -24.1% |
| Q3 FY2020 | Sep 30, 2020 | $350.51M | -25.7% |
| Q2 FY2020 | Jun 30, 2020 | $385.34M | +52.3% |
| Q1 FY2020 | Mar 31, 2020 | $414.24M | +54.0% |
| Q4 FY2019 | Dec 31, 2019 | $448.63M | +63.8% |
| Q3 FY2019 | Sep 30, 2019 | $471.59M | +67.8% |
| Q2 FY2019 | Jun 30, 2019 | $253.08M | -18.0% |
| Q1 FY2019 | Mar 31, 2019 | $268.99M | +39.9% |
| Q4 FY2018 | Dec 31, 2018 | $273.91M | +30.7% |
| Q3 FY2018 | Sep 30, 2018 | $281.06M | +102.2% |
| Q2 FY2018 | Jun 30, 2018 | $308.54M | +95.3% |
| Q1 FY2018 | Mar 31, 2018 | $192.24M | +13.3% |
| Q4 FY2017 | Dec 31, 2017 | $209.64M | +10.2% |
| Q3 FY2017 | Sep 30, 2017 | $138.99M | – |
| Q2 FY2017 | Jun 30, 2017 | $157.97M | – |
| Q1 FY2017 | Mar 31, 2017 | $169.64M | – |
| Q4 FY2016 | Dec 31, 2016 | $190.27M | – |
See a number that looks wrong?